Product Images Glatiramer Acetate

This is a chemical formula that appears to contain amino acids such as Glutamine, Alanine, Lysine, and Tyrosine. It also includes other chemical representations. The CAS number provided is 147245-92-9.*

This description appears to show a figure depicting the "Time to Second Exacerbation" and the corresponding percentage of "Second Exacerbation" for a placebo and glatiramer acetate injection. The results indicate a statistically significant difference (p=0.0005) with a hazard ratio of 0.55 favoring the treatment group. The data is presented on "Day 80".*

This text seems to provide information about a study or trial involving the comparison of 16 s Glatiramer acetate injection with a placebo in relation to the cumulative number of enhancing lesions. The figure displays the median cumulative number of Gd-enhancing lesions for a certain period. This study could be related to a medical condition or treatment process where these lesions are of relevance.*

This text appears to be a description of a medication product called Glatiramer Acetate Injection. It comes in single-dose pre-filled syringes containing 1 mL of solution, with each syringe containing 20 mg of glatiramer acetate and 40 mg of mannitol (an inactive ingredient). The text mentions storage conditions (refrigerated at 36°F to 46°F), dosage instructions (inject 20 mg once daily), and the manufacturer (Zydus Pharmaceuticals (USA) Inc.). It is intended for subcutaneous injection and includes dispensing and medication guide information for patients.*

This text provides information about a pharmaceutical product called Glatiramer Acetate Injection, which is intended for subcutaneous injection. The medication comes in the form of 12 single-dose pre-filled syringes, each containing 1 mL of the solution. The dosage recommendation is to inject 40 mg three times a week. It is essential to store the medication refrigerated at 36°F to 46°F (2°C to 8°C) and protect it from light. The manufacturer is indicated as "talfarmaco S.p A" in Italy, and distribution is done by "2ydus Pharmaceuticals (USA) Inc." in Pennington, NJ 08534. The text also mentions the presence of an enclosed Medication Guide to be provided to each patient for guidance.*

This text appears to be describing different body parts in relation to certain distances or coordinates such as "about 2 inches around the fleshy areas of the upper body," "belly button below the waist," "above the knee and 2 inches below the shin." It seems to be detailing specific measurements and locations on the abdomen, back of hips, arms, thighs, and lower body.*